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ABSTRACT
Purpose: We investigated complications after laparoscopic sentinel basin dissection (SBD) 
for patients with gastric cancer who were enrolled in a quality control study, prior to the 
phase III trial of sentinel lymph node navigation surgery (SNNS).
Materials and Methods: We analyzed prospective data from a Korean multicenter 
prerequisite quality control trial of laparoscopic SBD for gastric cancer and assessed 
procedure-related and surgical complications. All complications were classified according 
to the Clavien-Dindo Classification (CDC) system and were compared with the results of the 
previously published SNNS trial.
Results: Among the 108 eligible patients who were enrolled in the quality control trial, 8 
(7.4%) experienced complications during the early postoperative period. One patient with 
gastric resection-related duodenal stump leakage recovered after percutaneous drainage 
(grade IIIa in CDC). The other postoperative complications were mild and patients recovered 
with supportive care. No complications were directly related to the laparoscopic SBD 
procedure or tracer usage, and there were no mortalities. The laparoscopic SBD complication 
rates and patterns that were observed in this study were comparable to those of a previously 
reported trial.
Conclusions: The results of our prospective, multicenter quality control trial demonstrate 
that laparoscopic SBD is a safe procedure during SNNS for gastric cancer.
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INTRODUCTION
Gastric cancer is a major health issue, the 5th most common malignancy, and third leading 
cause of cancer-related death worldwide, according to GLOBOCAN 2012 [1]. Although 
the standard treatment for gastric cancer is surgical resection of the stomach with radical 
lymphadenectomy, excessive lymph node (LN) dissection increases patient morbidity and 
mortality, and gastrectomy itself decreases the quality of life of patients with gastric cancer. 
Therefore, if we can predict the LN metastasis status before or during the operation, a 
tailored gastrectomy, such as a wedge resection or limited LN dissection, would be possible, 
especially for early cancer.
Sentinel lymph node (SN) biopsies for predicting metastatic LNs have been widely used in 
breast cancer and melanoma. However, the clinical application of SN biopsies for gastric 
cancer has been challenging, due to complicated multidirectional lymphatic drainage around 
the stomach, and the risk of skip metastasis or false-negative intraoperative histological 
examinations in gastric cancer [2,3]. SN biopsy methods and techniques have gradually 
evolved for gastric cancer, and a recent Japanese study showed promising results in SN 
navigation surgery detection and sensitivity [4]. In Korea, the SENtinel NOde ORIented 
Tailored Approach (SENORITA) study group planned a multicenter phase III trial that 
compared conventional laparoscopic gastrectomy to laparoscopic SN biopsy with limited 
gastrectomy in patients with clinical stage Ia gastric cancer. Before beginning this phase III 
trial, we performed a quality control study to qualify the institutions that were participating 
in the phase III trial and to standardize the surgical procedures [5].
SN biopsy in gastric cancer is a difficult procedure, with a steep learning curve [6]. Many 
factors, such as endoscopic dual tracer injection into the submucosa, detection of the SN 
basin that is hidden under perigastric fat tissues, successful sentinel basin dissection (SBD) 
without major bleeding or gastric wall injury, and SN identification at the back table affect 
the outcomes of successful sentinel lymph node navigation surgery (SNNS). In particular, 
avoiding postoperative complications that are related to the SBD procedure is important 
for the early recovery of patients and the continuous application of SNNS. Therefore, in 
this quality control study, we investigated the operative and postoperative complications, to 
clarify the safety of the SBD procedure.
MATERIALS AND METHODS
We have previously described the methods of this prospective, multicenter feasibility quality 
control trial in detail [5,7].
We enrolled patients with gastric cancer who were between 20 and 80 years of age and of 
clinical stage T1-2N0M0, according to the American Joint Committee on Cancer (AJCC), 7th 
edition [8]. Indications for this prospective, multicenter quality control trial included that the 
longest tumor diameter was less than 4 cm, under endoscopic measurement, and the tumor 
was located at least 2 cm from the pylorus or cardia. Patients who had absolute indications for 
endoscopic submucosal dissection (ESD) were excluded in this study. Totally 7 institutions of 
SENORITA study group participated in this prospective quality control trial, and all data from 
patients were registered in a central data center (eVelos System; Velos, Inc., Fremont, CA, 
USA). Before the laparoscopic SBD surgery, all patients provided written informed consent. All 
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participating institutions had approval by the local Institutional Review Boards for this study. 
(approval number: D-1201-002-002 at the institution of corresponding author)
A minimum of 10 cases of success for all 7 steps were required at each institution, for 
participation in the subsequent phase III trial for qualification into this study. The success 
for each case in this quality control trial means the completion of 7 steps for assessing the 
adequacy of the procedure that were performed by the endoscopists, surgeons, and pathologists 
in each institution [5,7]. Step 1 testifies which the tracer was injected by intraoperative 
esophagogastroduodenoscopy (EGD) at the submucosal layer or not. Step 2 involves the 
intraoperative EGD tracer injection at adequate 4 sites. Step 3 is assessment of the presence or 
absence of intraluminal or extraluminal tracer leakage, during intraoperative EGD injection. 
Step 4 means the injection of tracers by intraoperative EGD within 3 minutes from the first to 
the fourth injection. Step 5 is the intraoperative laparoscopic identification of at least one SB. 
Step 6 indicates which the SBNs were evaluated by intraoperative frozen biopsy or not. Lastly, 
step 7 is the identification of at least 5 isolated SBNs, and the analysis of frozen sections.
Fig. 1 illustrates the SBD procedure. To detect SNs, a mixture of indocyanine green (ICG; 
Diagnogreen1, 2 mL, 5 mg/mL, Daiichi-Sankyo Co., Ltd., Tokyo, Japan) and human serum 
albumin with radiolabel (Tc99m-HSA; 2 mL, 0.1 mCi/mL) was used as a dual tracer. In the 
first step of the surgery, the dual tracer was injected into the submucosal layer, in the 4 
quadrants of the gastric tumor (1 mL at each quadrant, for a total volume of 4 mL), via an 
intraoperative endoscopic approach. During the endoscopic injections, we laparoscopically 
monitored the serosal layer of the stomach, to prevent intragastric or intraperitoneal tracer 
leakage. Fifteen minutes after endoscopic injection of the dual tracer, stained lymphatic 
vessels and LNs were identified. Afterward, a laparoscopic handheld gamma probe was 
applied to detect radioactive SNs. At this time, each side of the stomach and the lesser and 
greater curvature sites were meticulously assessed. The sentinel basin (SB) margins were 
marked by laparoscopic clips. SBs containing SNs were carefully dissected, within the marked 
sites, and retrieved from the surgical field. The harvested SBs were dissected, to isolate LNs. 
All isolated LNs from the SBs were defined as sentinel basin nodes (SBNs), which refer to LNs 
located completely within the SB.
SBNs were classified into 4 types of SBNs: hot node (HN), green node (GN), both hot and 
green node (HGN), and basin node (BN), as described in our previous report [5,7]. The GN 
shows only ICG uptake, without Tc99m-HSA, HN shows 99mTc-HSA uptake, without ICG 
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Fig. 1. The steps of laparoscopic SBD. (A) Endoscopic injection of Tc99m-HSA with ICG and a laparoscopic view after tracer injection. (B) Laparoscopic sentinel 
basin node detection along the greater and lesser curvatures of the stomach. (C) Surgical clip application for marking the extent of laparoscopic SBD in the 
greater and lesser curvatures of the stomach. (D) Laparoscopic SBD along the greater and lesser curvatures of the stomach. (E) Completion of laparoscopic SBD 
along the greater and lesser curvatures of the stomach. 
SBD = sentinel basin dissection; ICG = indocyanine green.
staining, and HGN presents concurrent uptake of ICG and 99mTc-HSA. A BN is a non-
sentinel node that is located within the same SB. In other words, LNs retrieved from an SB 
that were neither green nor hot were defined as BNs. All SBNs were extracted during surgery 
and sent to a pathologist for intraoperative frozen sectioning. LNs that were harvested 
from the SBs were histologically examined intraoperatively, with hematoxylin and eosin 
(H&E) staining, using a single, cut plane of a frozen section. Standard gastrectomy, with 
lymphadenectomy of D1+ or more, was performed after SBD in all patients, according to the 
Japanese gastric cancer treatment guidelines [9]. After conventional surgery, the remaining 
LNs were classified by LN station, according to the anatomical definition of the Japanese 
guidelines, and sent for permanent pathologic examination by H&E staining [10].
All of SBD procedure-related or surgical complication data from the Korean multicenter 
prerequisite quality control trial were classified according to the Clavien-Dindo Classification 
(CDC) [5,11]. Also, the data were compared to the results of another multicenter prospective 
SNNS trial, which demonstrated the feasibility of gastric cancer SN mapping with the dual 
tracer method in Japan [4].
RESULTS
Among the 112 patients who were preoperatively enrolled at 7 institutions, 4 were excluded 
because of screening failures, 2 withdrew after enrollment, 1 had double primary cancer, and 
1 had poor bowel preparation for the intraoperative endoscopic procedure. Consequently, 
108 patients were eligible for the final analyses, 8 of whom (7.4%) experienced postoperative 
complications in the early postoperative period, within 30 days after surgery.
Table 1 shows the details of the 8 cases with complications, which included 1 with duodenal 
stump leakage, 2 with pancreatitis, 3 with gastric stasis, 1 with ileus, and 1 with bleeding. 
The patient with duodenal stump leakage recovered after percutaneous drainage and was 
classified with a grade IIIa complication, under the CDC. The other complications were mild 
and recovered with supportive care. There were no complications directly related to the SBD 
procedure, and there were no cases of mortality. In addition, there were no serious allergic 
reactions during or after tracer injection after surgery. Intraoperative endoscopic injections 
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Table 1. Details of the 8 cases with complications
No. Sex Age BMI ECOG 
performance 
status
Longitudinal 
location of 
tumor
Circumferential 
location of 
tumor
pT Tumor 
size 
(cm)
Histology Location 
of SB
No. 
of 
SNs
No, of total 
harvested 
LNs
pN OP 
name
OP 
time 
(min)
Hospital 
stay 
(day)
Complications CDC
1 F 54 17 0 Middle PW T1a 2.5 Tub-
Adenoca
# 3, 7 15 44 0 LDG 287 19 Pancreatitis I
2 M 48 23 0 Middle LC T1a 3.2 Tub-
Adenoca
# 3 1 28 0 LDG 155 23 Duodenal stump 
leakage
IIIa
3 F 74 25 1 Middle PW T1a 2.0 SRC-Ca # 3, 5 7 25 0 LDG 405 17 Ileus I
4 F 70 26 0 Lower PW T1a 2.0 SRC-Ca # 4d 2 29 0 LDG 210 9 Intraluminal 
bleeding
II
5 F 77 23 0 Middle PW T2 2.0 Tub-
Adenoca
# 3 5 17 0 LDG 150 11 Gastric stasis II
6 F 59 25 0 Lower LC T1a 1.6 Tub-
Adenoca
# 3 8 51 0 LDG 249 8 Pancreatitis I
7 M 32 18 0 Lower PW T1a 1.7 SRC-Ca # 4d 7 50 0 LDG 245 9 Gastric stasis I
8 F 46 22 0 Lower GC T1a 0.5 SRC-Ca None 0 20 0 LDG 239 9 Gastric stasis I
BMI = body mass index; ECOG = Eastern Cooperative Oncology Group; PW = posterior wall; LC = lesser curve; GC = greater curve; Tub-Adenoca = tubular 
adenocarcinoma; SRC-Ca = signet-ring cell carcinoma; SB = sentinel basin; SN = sentinel lymph node; LN = lymph node; LDG = laparoscopic distal gastrectomy; 
OP = surgery; CDC = Clavien-Dindo Classification.
were completely performed within 3 minutes in all of the cases with complications. The 
average hospital stay length of the 8 cases with complications was 13.1 days. For the patient 
with duodenal stump leakage, the length of hospital stay was 23 days, which was the longest 
of the 8 complications.
In Table 2, we compare our surgical complication results to those of the Japanese SNNS 
trial [4]. The incidence of postoperative complications was 7.4% (8/108) in our study and 
4.5% (18/397) in the Japanese SNNS trial. In the Japanese study, intraabdominal abscesses 
and small bowel ileuses were common complications, followed by pneumonia, bleeding, 
anastomotic leakage, stenosis, and thrombus or embolism. The Japanese SNNS trial did not 
report any abnormal reactions that were related to dual tracer injections.
DISCUSSION
The incidence of complications was 7.4% (8/108), and only one grade IIIa complication 
developed in this quality control study for laparoscopic SBD. In addition, there were no 
cases of allergic reactions after tracer injections. Considering that all patients recovered 
successfully, the SBD procedure appears safe and without additional risks.
In gastric cancer, SBD, which is also called sentinel lymphatic basin dissection, has been 
reported to be better than the pick-up method for successful SNNS [12,13]. The detection 
rate of SNs was determined to be 54.8% by the pick-up method and 96% by SBD [14]. 
Therefore, the SENORITA study in Korea and the Japanese prospective multicenter trial 
performed the SBD procedure for SNNS. Also, we anticipate that SBD will be the standard 
surgical procedure for SNNS in the future. In addition, even though our study was a quality 
control trial that took place prior to the phase III trial, our data support the successful and 
safe completion of the phase III trial.
In the previous Japanese study, there was no significant increase in the number of postoperative 
complications that were caused by the SN biopsy procedures, and no serious allergic reactions 
were observed after tracer injection. The authors observed only transient pigmentation (0.3%) 
and decreased pulse oximeter oxygen saturation (0.8%) [4]. ICG is a widely used material for 
determining cardiac output, hepatic function, and liver blood flow and is commonly used 
in ophthalmic angiographies. It is also used for SN mapping in breast cancer, malignant 
melanoma, and gastrointestinal tumors. The allergic reactions to ICG include facial flushing, 
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Table 2. Comparison of complications that were observed in the Japanese Society of SNNS and Korean SENORITA QC trials
Postoperative complications Korean SENORITA QC trial (n=108) 
No. (%)
Japanese Society of SNNS trial (n=397) [4] 
No. (%)
Pneumonia 2 (0.5)
Anastomotic leakage 1 (0.3)
Duodenal stump leakage 1 (0.9)
Pancreatitis or pancreatic leakage 2 (1.9) 2 (0.5)
Intra-abdominal abscess 5 (1.3)
Anastomotic stenosis 1 (0.3)
Gastric stasis 3 (2.8)
Small bowel ileus or obstruction 1 (0.9) 4 (1.0)
Bleeding 1 (0.9) 2 (0.5)
Thrombus/embolism 1 (0.3)
Total 8 (7.4) 18 (4.5)
SNNS = sentinel lymph node navigation surgery; SENORITA = SEntinel NOde ORIented Tailored Approach; QC = quality control.
hypotension, tachycardia, urticaria, pruritus, dyspnea, and anaphylactic shock, which rarely 
develop when ICG is injected with incomplete dissolution [15]. The maximum radiation dose 
of Tc99m-HSA that was used in this study was 0.4 mCi, which is only 1.3% of the 30 mCi that 
is commonly performed for bone scans [16]. However, because radioisotope usage has some 
disadvantages, such as high cost, radioactivity, and handling difficulty, ICG fluorescence 
imaging SN mapping has been recently introduced for SNNS in gastric cancer [17,18].
A previous analysis of the Korean surgery study group trial found that the immediate 
postoperative morbidity was 11.6%, after laparoscopy-assisted distal gastrectomy [19]. Also, 
a retrospective multicenter study of laparoscopic gastrectomy by the Japanese and Korean 
laparoscopic surgery study groups reported morbidity rates of 14.8% and 15.1%, respectively 
[20,21]. Although a relatively small number of patients was enrolled in the present study, 
the incidence of complication (7.4%, 8/108) was similar or less than other studies. In this 
quality control study, all patients underwent conventional laparoscopic gastrectomy with 
D1+ or more LN dissections. We observed a few complications that were derived only from 
conventional gastrectomy, and no additional risks were associated with the dual tracer 
injection and SBD procedures.
The SENORITA multicenter, phase III, randomized control trial for individualized function-
preserving gastrectomies, including gastric wedge resection, segmental gastrectomy, and 
intraoperative ESD with SBD for T1N0 gastric cancer, is currently underway in Korea [22,23]. 
Even though the surgical complications for laparoscopic-limited function-preserving 
gastrectomies, such as wedge resection, segmental resection, or partial gastrectomy, could 
not be evaluated in this quality control study, we will report the SBD procedure and surgery-
related complications from the SENORITA trial in the near future.
In conclusion, no complications were directly related to the laparoscopic SBD procedures 
that were performed in our study. Laparoscopic SBD is a safe procedure, based on the results 
of our prospective, multicenter feasibility quality control trial, which was performed prior to 
the phase III trial.
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